Department of Medicine, Clinic of Otorhinolaryngology, Head and Neck Surgery, Technical University of Dresden, Fetscherstraße 74, 01307, Dresden, Germany.
Department of Otorhinolaryngology, Head and Neck Surgery, Cochlear Implant Centre, Catholic Hospital Koblenz-Montabaur, Koblenz, Germany.
Eur Arch Otorhinolaryngol. 2020 Jan;277(1):55-60. doi: 10.1007/s00405-019-05667-3. Epub 2019 Sep 30.
The primary objective of the retrospective study was to collect speech intelligibility data on children and adolescents implanted with the vibrating ossicular prosthesis (VORP) 503.
This was a retrospective, multicentre study on 55 children and adolescents from 6 German clinics aged between 5 and 17 years suffering from mixed or conductive hearing loss implanted with a VORP 503. Pre- and postoperative bone-conduction pure tone thresholds were measured at 0.5, 1, 2 and 4 kHz, and word recognition scores in the unaided and VORP 503-aided conditions using monosyllabic speech intelligibility tests measured at 65-dB sound pressure level (SPL) were determined.
Mean pre- and postoperative bone-conduction thresholds remained unchanged, showing the preservation of inner ear hearing. Speech intelligibility assessed in quiet at 65-dB SPL improved on average from 24.5% (SD ± 25.4) unaided to 86.4% (SD ± 13.4) aided. The average improvement of 61.9% (SD ± 25.3) was clinically and statistically significant. A total of three complications were found in the medical records of 55 subjects. The responsible investigators judged these events as procedure related.
The treatment of children suffering from conductive or mixed hearing loss with the VORP 503 implant demonstrates excellent aided benefit in terms of speech understanding and only minor complications.
本回顾性研究的主要目的是收集植入振动骨导假体(VORP)503 的儿童和青少年的言语可懂度数据。
这是一项来自 6 家德国诊所的 55 名 5 至 17 岁混合性或传导性听力损失儿童和青少年的回顾性多中心研究,他们植入了 VORP 503。在 0.5、1、2 和 4 kHz 处测量术前和术后骨导纯音阈值,在 65-dB 声压级(SPL)下使用单音节言语可懂度测试测量未助听和 VORP 503 助听条件下的言语识别得分。
平均术前和术后骨导阈值保持不变,表明内耳听力得到保留。在 65-dB SPL 的安静环境下评估的言语可懂度平均从未助听的 24.5%(SD ± 25.4)提高到 86.4%(SD ± 13.4)。61.9%(SD ± 25.3)的平均改善具有临床和统计学意义。在 55 名受试者的医疗记录中发现了 3 种并发症。负责的调查人员认为这些事件与手术有关。
对于患有传导性或混合性听力损失的儿童,使用 VORP 503 植入物治疗在言语理解方面具有出色的辅助获益,且仅出现轻微并发症。